U.S. flag

An official website of the United States government

NM_001005242.3(PKP2):c.235C>T (p.Arg79Ter) AND Cardiovascular phenotype

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 17, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000246785.12

Allele description [Variation Report for NM_001005242.3(PKP2):c.235C>T (p.Arg79Ter)]

NM_001005242.3(PKP2):c.235C>T (p.Arg79Ter)

Gene:
PKP2:plakophilin 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12p11.21
Genomic location:
Preferred name:
NM_001005242.3(PKP2):c.235C>T (p.Arg79Ter)
Other names:
p.R79*:CGA>TGA
HGVS:
  • NC_000012.12:g.32879021G>A
  • NG_009000.1:g.22826C>T
  • NM_001005242.3:c.235C>TMANE SELECT
  • NM_004572.4:c.235C>T
  • NP_001005242.2:p.Arg79Ter
  • NP_004563.2:p.Arg79Ter
  • NP_004563.2:p.Arg79Ter
  • LRG_398t1:c.235C>T
  • LRG_398:g.22826C>T
  • LRG_398p1:p.Arg79Ter
  • NC_000012.11:g.33031955G>A
  • NM_004572.3:c.235C>T
  • NM_004572.4:c.235C>T
  • c.235C>T
  • p.Arg79X
Protein change:
R79*; ARG79TER
Links:
OMIM: 602861.0001; dbSNP: rs121434420
NCBI 1000 Genomes Browser:
rs121434420
Molecular consequence:
  • NM_001005242.3:c.235C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_004572.4:c.235C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000318240Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Dec 17, 2021)
germlineclinical testing

PubMed (13)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy.

Gerull B, Heuser A, Wichter T, Paul M, Basson CT, McDermott DA, Lerman BB, Markowitz SM, Ellinor PT, MacRae CA, Peters S, Grossmann KS, Drenckhahn J, Michely B, Sasse-Klaassen S, Birchmeier W, Dietz R, Breithardt G, Schulze-Bahr E, Thierfelder L.

Nat Genet. 2004 Nov;36(11):1162-4. Epub 2004 Oct 17. Erratum in: Nat Genet. 2005 Jan;37(1):106.

PubMed [citation]
PMID:
15489853

Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy.

van Tintelen JP, Entius MM, Bhuiyan ZA, Jongbloed R, Wiesfeld AC, Wilde AA, van der Smagt J, Boven LG, Mannens MM, van Langen IM, Hofstra RM, Otterspoor LC, Doevendans PA, Rodriguez LM, van Gelder IC, Hauer RN.

Circulation. 2006 Apr 4;113(13):1650-8. Epub 2006 Mar 27.

PubMed [citation]
PMID:
16567567
See all PubMed Citations (13)

Details of each submission

From Ambry Genetics, SCV000318240.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (13)

Description

The p.R79* pathogenic mutation (also known as c.235C>T), located in coding exon 2 of the PKP2 gene, results from a C to T substitution at nucleotide position 235. This changes the amino acid from an arginine to a stop codon within coding exon 2. This alteration has been described in numerous individuals and families with arrhythmogenic right ventricular cardiomyopathy (ARVC) and was determined to be a Dutch founder mutation associated with reduced penetrance and variable expressivity (van der Zwaag PA et al. Neth Heart J. 2010;18(12):583-91). Functional in vitro analysis demonstrated poor localization to the cell membrane and altered desmosomal protein interactions with reduced expression (Joshi-Mukherjee R et al. Heart Rhythm. 2008;5:1715-1723). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024